Juvenile OLFM4-null mice are protected from sepsis.

Area of Science:

• Pediatric critical care medicine
• Nephrology
• Immunology

Background:

• Pediatric sepsis is a major cause of child mortality.
• Sepsis-associated acute kidney injury (AKI) is common but poorly understood.
• Olfactomedin-4 (OLFM4) is linked to poor sepsis outcomes.

Purpose of the Study:

• Investigate the role of OLFM4 in pediatric sepsis-induced AKI.
• Elucidate the mechanisms of OLFM4 in sepsis.
• Determine if OLFM4 contributes to kidney injury during sepsis.

Main Methods:

• Utilized a pediatric murine model of sepsis.
• Compared survival rates between wild-type and OLFM4-null mice.
• Performed immunohistochemistry to assess OLFM4 expression in kidneys.
• Measured renal cell apoptosis and plasma creatinine levels.
• Conducted bone marrow transplant experiments.

Main Results:

• OLFM4-null mice showed significantly increased survival after sepsis induction.
• Increased OLFM4 expression was observed in the kidney's loop of Henle in septic wild-type mice.
• Renal cell apoptosis and plasma creatinine were elevated in wild-type compared to OLFM4-null mice.
• Bone marrow transplant indicated local kidney production of OLFM4.

Conclusions:

• Renal expression of OLFM4 is demonstrated for the first time.
• OLFM4 may play a kidney-specific role in sepsis pathogenesis.
• Targeting OLFM4 could offer a therapeutic strategy for pediatric sepsis-AKI.